RNPC3 and pulmonary arterial hypertension: Moreover, there were also significant increased sensitivity in 2013 than 1980 criteria in disease duration < 3 or ≥ 3 years, presence or absence of Sclerodactyly, telangiectasia, PAH, ILD, ACA and anti-RNP antibody.